Wordt geladen...
The latest advances in β-lactam/β-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections
INTRODUCTION: Antimicrobial resistance in Gram-negative pathogens is a significant threat to global health. β-Lactams (BL) are one of the safest and most-prescribed classes of antibiotics on the market today. The acquisition of β-lactamases, especially those which hydrolyze carbapenems, is eroding t...
Bewaard in:
| Gepubliceerd in: | Expert Opin Pharmacother |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6834881/ https://ncbi.nlm.nih.gov/pubmed/31500471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14656566.2019.1660772 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|